Boston Scientific Corporation announced that Yoshiaki Fujimori will not stand for re-election to the Board of Directors at the company’s 2026 Annual Meeting. Fujimori, who has served on the board since 2016 and is chair of the Risk, Science and Technology Committee, will continue in his roles until the meeting. The board is evaluating whether to add new directors following his departure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000885725-26-000008), on February 05, 2026, and is solely responsible for the information contained therein.